The voice was calm, unhurried, as though Sorensen had merely paused a routine laboratory inspection to greet an expected colleague. Celeste stepped out from behind the equipment rack, her body tense, her mind racing through options. Voss remained in the shadows, his presence still hidden.
"Dr. Sorensen," she said. "You were expecting me."
"I was expecting someone. The unlocked fence, the open door, the conveniently timed security gap—did you think those were oversights?" He turned from the monitors, his face illuminated by the pale glow of Hassan's dream display. "I've been following your investigation since you published the first story. You're thorough. Determined. Qualities I admire, even when they inconvenience me."
"Then you know why I'm here."
"You're here for Mr. Hassan. And you're here because you've realized that the Ironhaven experiments were only one piece of a larger puzzle." He gestured toward the monitors. "The weaponization program was never the point, Ms. Moreau. The calibration, the dosages, the crystallization thresholds—that was Marcus Vinter's obsession. He wanted to build a better nerve agent. I wanted something far more interesting."
"What?"
"The human brain produces a remarkable array of neurochemical activity during the process of dying. Near-death experiences, life reviews, visions of tunnels and lights—these are not hallucinations. They are measurable, reproducible neurological phenomena. And they are accompanied by the release of a rare neuropeptide that we call thanatophorin. Death-bringer. It exists in the brain for only a few seconds at the moment of clinical death. No one has ever been able to study it in real time. Until now."
Celeste looked at Hassan, whose eyelids continued to flutter, whose brain cycled endlessly through REM sleep at an intensity that was consuming him from within. "You're killing him to study a neuropeptide?"
"Not killing him. Prolonging the moment of death. The Lazarus-9 compound, in its unweaponized form, creates the same neurochemical cascade that occurs during the dying process. But it does so slowly. Controllably. The crystallization is not a bug, Ms. Moreau. It's the feature. It allows us to stretch the moment of death across weeks instead of seconds. And in those weeks, the dreaming brain produces thanatophorin in quantities that would normally require hundreds of deaths to accumulate."
Voss stepped out of the shadows, his face pale with horror. "You're harvesting it. The dreams, the memories—you're extracting thanatophorin from living subjects."
"Elias," Sorensen said, and for the first time, a flicker of genuine surprise crossed his face. "I didn't expect you to come in person. I assumed you'd be at St. Jude's, helping Roscoe develop her antagonist. She's quite talented, by the way. I've been monitoring her research. The benzodiazepine scaffold was a clever choice."
"You're not harvesting a neuropeptide for pure research," Voss said. "Thanatophorin has no known therapeutic value. It's too unstable. It degrades within minutes of extraction. The only thing it could be used for is—"
"Intelligence," Celeste finished. "You're not killing people for a chemical. You're killing them for what they see when they die."
Sorensen smiled. It was not a cruel smile. It was the smile of a teacher whose student had finally grasped a difficult concept. "The dying brain does not simply produce chemicals, Ms. Moreau. It produces information. During the life review—the phenomenon that near-death experiencers describe as 'seeing their life flash before their eyes'—the brain replays its entire memory archive in a compressed burst of neural activity. Every face, every conversation, every secret ever learned. It's all there. And with the right receptor technology, it can be decoded."
"You're extracting memories from dying prisoners."
"We're extracting intelligence. Some of the subjects at Ironhaven were not merely criminals. Several had connections to foreign intelligence services. One was a former cryptographer who had worked on classified communications protocols. Another was a courier for a network that moved sensitive materials across international borders. Their memories, accessed during the prolonged dying process, have yielded information that has prevented at least two terrorist attacks and exposed a foreign espionage network operating in our government."
Sorensen's voice was reasonable, measured, the voice of a man explaining a difficult but necessary decision. Celeste felt a cold wave of revulsion wash over her.
"You're justifying torture," she said. "Killing prisoners to harvest their memories. That's not intelligence gathering. That's a human rights atrocity."
"Atrocities are what enemies do to us. This is what we do to protect ourselves. The program is authorized under a classified executive order signed three years ago. It's legal, Ms. Moreau. It's just not public. And now that you know about it, you have a choice to make."
"What choice?"
"The same choice I gave Dr. Gauthier when he discovered the weaponization side of the research. The same choice I gave Dr. Fielding when she found the crystals in Strand's blood. You can cooperate, or you can be silenced. Gauthier chose silence and was buried in Ironhaven. Fielding chose silence and was buried in St. Dymphna. Both are still alive, I should note. I don't kill whistleblowers. I simply... relocate them."
"And if I don't cooperate?"
Sorensen reached into his lab coat and withdrew a tablet. The screen displayed a live security feed from the hospital—from Gauthier's room, Celeste realized with a jolt. A figure in a nurse's uniform stood beside his bed, adjusting an IV line. The figure's movements were too precise, too deliberate.
"The antagonist Dr. Roscoe is developing will never be finished," Sorensen said. "Because in approximately two minutes, the IV line in Gauthier's arm will deliver a dose of concentrated Lazarus-9 that will raise his crystallization index past the threshold within hours. The same will happen to Havelock. And to Fielding, who was transferred to St. Jude's this morning. All three of your witnesses will die of natural causes—neurological failure, exactly as the Ironhaven inmates died. The evidence will die with them. And you will be left with nothing but unsubstantiated allegations and a very aggressive federal prosecution for leaking classified material."
Celeste stared at the security feed, her heart hammering. "You're bluffing."
"Am I? The nurse at Gauthier's bedside is one of my people. She's been embedded at St. Jude's for six months, waiting for exactly this contingency. I have similar assets at the Sentinel, at the State Ombudsman's office, and in the Veridia Police Department. You've been playing chess against an opponent who can see your pieces and move them at will."
"Then why haven't you already killed them?"
"Because I don't want to kill anyone, Ms. Moreau. I'm not a murderer. I'm a researcher who has been tasked with an unpleasant but necessary duty. The thanatophorin program has yielded intelligence that has saved lives—many more lives than the prisoners who have died. I take no pleasure in their deaths. I simply accept them as the cost of a greater good."
"The greater good. Every atrocity in history has been justified with those words."
"Perhaps. But that doesn't make the words false. It simply means that the people who speak them must be willing to bear the moral weight of what they do. I am willing. The question is whether you are willing to bear the weight of what will happen if you refuse my offer."
The room was silent except for the soft hum of the monitors and the steady beep of Hassan's heart rate. Celeste looked at the security feed, at the nurse adjusting Gauthier's IV line, at the seconds ticking down toward the deadline Sorensen had set.
"What's your offer?" she asked.
"Simple. You stop publishing. The investigation stalls. The Stellan Archipelago story fades from the news cycle. In exchange, Gauthier, Havelock, and Fielding survive. Roscoe is allowed to complete her antagonist research. The criminal cases against the Ironhaven researchers proceed—we'll sacrifice Vinter and a few technicians as scapegoats. The public gets its accountability. You get your story, sanitized and incomplete. And the thanatophorin program continues, quietly, in facilities that are even more secure than this one."
"And Hassan?"
"Hassan is too far gone. His crystallization index is at ninety-one percent. Even if we stopped the infusion now, he would die within days. His sacrifice has already yielded substantial intelligence. I won't pretend he can be saved."
"You're asking me to trade one man's life for three others."
"I'm asking you to be pragmatic. Hassan is dying regardless. Gauthier, Havelock, and Fielding can still be saved. But only if you cooperate."
Celeste looked at Voss, who stood rigid with fury, his hands clenched at his sides. She looked at Hassan, whose face twitched with the intensity of dreams that were being harvested even as his body failed. She looked at the security feed, at the clock on the wall that showed thirty seconds remaining.
"Call off the nurse," she said. "I'll cooperate."
Sorensen smiled and tapped his tablet. On the security feed, the nurse stepped away from Gauthier's IV line and walked out of the room. "Wise choice."
"But I have conditions. Hassan is transferred to St. Jude's. Not to be saved—you said yourself he can't be saved. But to die with dignity, surrounded by doctors who aren't harvesting his memories. And I want full documentation of the thanatophorin program. Not for publication. For leverage. If anything happens to Gauthier, Havelock, or Fielding, the documentation goes public. Every news outlet, every human rights organization, every foreign government that will listen. You let them live, and I keep your secrets. That's the deal."
Sorensen studied her for a long moment. His gray eyes were unreadable, the eyes of a man who had spent years calculating human behavior and was running the equations now, weighing costs and benefits, risks and rewards.
"Agreed," he said. "Hassan will be transferred within the hour. The documentation will be delivered to your encrypted server by morning. And you will publish nothing further about Ironhaven, the Stellan Archipelago, or this facility. The Sentinel will report that the investigation has concluded, that Neurovance has cooperated fully, and that the rogue researchers have been identified and prosecuted. The public will have its closure, and we will have our silence."
"And Parris? The Deputy Warden?"
"Parris is in the Stellan Archipelago, where she will remain. She's no longer your concern."
Sorensen extended his hand. Celeste looked at it for a long moment, then shook it. His grip was cool and dry, the grip of a man who had shaken hands over deals that had ended lives and called it progress.
"Dr. Voss will arrange the transfer details with your medical team," Sorensen said. "You should return to St. Jude's. Mr. Gauthier will be wondering where you've gone."
He turned back to his monitors, dismissing them as thoroughly as if they had already left the room. Celeste and Voss walked out of the laboratory, down the corridor, through the unlocked door and the gap in the fence, and into the cold night air.
"You're not really going to keep his secrets," Voss said as they reached the car.
"No. But I need time. Time for Roscoe to finish the antagonist. Time for Gauthier and Havelock to recover enough to testify. Time to find a way to expose the thanatophorin program without getting them killed." She slid into the driver's seat and gripped the steering wheel. "Sorensen thinks he's won. He thinks he's bought my silence with a deal. But he just confirmed everything I suspected and gave me a new target. The thanatophorin program isn't authorized by any legitimate legal authority. It's not in the Advanced Neurological Countermeasures Act. It's not in any executive order. It's Sorensen's private project, and he's been running it under the cover of the weapons program."
"How do you know that?"
"Because if it were truly authorized, he wouldn't need my silence. He would have just classified the program and had me prosecuted for revealing it. The fact that he's negotiating means he's exposed. The thanatophorin research is his secret. Not Neurovance's secret. Not the government's secret. His. And secrets that belong to one man can be unraveled."
She started the car and drove toward St. Jude's, the city lights blurring past the windows. Behind them, in the unmarked building on Harrow Lane, Nadir Hassan continued to dream his dying dreams, his memories being harvested by machines that Sorensen had built in secret. But not for much longer. The deal Sorensen had made would save three lives, but it would also bring Hassan to St. Jude's, where Roscoe could examine him, where Celeste could document his condition, where every piece of evidence Sorensen had tried to hide would be preserved by doctors who answered to no pharmaceutical contract.
The deal was a retreat. But retreats, Celeste had learned, were sometimes the only way to survive long enough to win.
At St. Jude's, she found Roscoe in the laboratory, her eyes shadowed with exhaustion, her hands steady as she calibrated the synthesizer that would produce the first batch of the antagonist.
"How close are you?" Celeste asked.
"Twenty-four hours. The fluorine modification worked. The binding affinity is strong enough to compete with the peptide. If the synthesis goes cleanly, we'll have a test batch by tomorrow evening."
"And Sorensen? He said he'd been monitoring your research."
Roscoe looked up, her expression sharp. "I know. I've been feeding him false data through a compromised server for the past six hours. He thinks the antagonist is seventy-two hours away. In reality, I'm ahead of schedule. The magnesium sulfate data I've been sending him is artificially elevated—Havelock's index isn't as high as Sorensen believes. We have more time than he thinks."
Celeste felt a fierce, exhausted smile cross her face. "You've been playing him."
"Since the moment Voss told me about the St. Dymphna raid. Sorensen monitors everything. The only way to beat him is to give him what he expects to see." She turned back to the synthesizer. "Get some rest, Ms. Moreau. The real fight hasn't started yet."
Celeste walked to the waiting room and collapsed into a chair. Through the window, the lights of Veridia glittered against the darkness. In the rooms behind her, Havelock and Gauthier slept under the protection of doctors who had outmaneuvered the man who thought he controlled everything. In a facility across the city, Hassan was being prepared for transfer to the same hospital where his testimony would become evidence. And somewhere in the Stellan Archipelago, Elaine Parris was consolidating a program that was already crumbling from within.
The deal with Sorensen had bought time. But time, Celeste knew, was a weapon that cut both ways.
No comments yet. Be the first to comment!